Plain-English translation of NCT07705035 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing a new cancer medication called in patients with various types of advanced solid tumors, including endometrial, ovarian, and lung cancers. The study happens in two stages: first, researchers test different doses to find the safest and most effective level, and then they confirm those findings in a larger group of patients. The goal is to learn how safe the medication is and whether it can help shrink or slow down tumors.
Many patients with advanced cancers need new treatment options because existing therapies may not work well enough or may stop working over time. This medication is being tested for the first time in humans to see if it offers a new way to treat these difficult-to-treat cancers.
You likely qualify if…
You likely don't qualify if…
In the first part of the trial, you will receive increasing doses of the medication to help doctors determine the safest and most effective dose. If that dose is then confirmed to be safe and promising, you may continue or new participants may join the second part of the study to receive that established dose and have their response monitored. Throughout participation, you will have regular visits for blood tests, imaging scans, and check-ins with the study team to track how you are tolerating the medication and how your cancer is responding.
AI-generated summary from trial data · Sep 3, 2026 · Not medical advice
United States